Efficacy of Bioceramic Materials for Bone Defects Repair
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNanjing First Hospital, Nanjing Medical University
About this trial
The purpose of this study is to demonstrate the effect of bioceramic implants on the repair of human bone defects, and to explore the application of bioceramic materials in bone defects, bone implantation, and bone fusion. The surface microstructure of β-tricalcium phosphate bioceramic implants can be effectively controlled to guide the regeneration of bones, promote the restoration of bones, accelerate the speed of recovery, and improve bone quality, which is of great clinical and social significance.
Eligibility criteria
Qualifiers
Patients who voluntarily take the test and sign the informed consent form;
Patients aged 18-65 years old with no history of allergies;
Patients able to communicate well with the investigator and follow the requirements of the entire trial.
Disqualifiers
Patients who refuse to sign the informed consent form to participate in the trial;
Patients who are not in the age range of 18 to 65 years;
Patients with diseases unsuitbale for the trial: history of allergies, severe cardiopulmonary disease, coagulation dysfunction, Alzheimer's disease, cerebral atrophy, acute phase or sequelae of cerebrovascular disease, cognitive impairment;
Patients in the acute phase of local or systemic bacterial infections;
Trial design
Treatments tested in this trial
- Commercial bone implant product Group
- Mirco-structured Bioceramic Group
Treatment groups
10 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov